← Back

Dr. V. Wee Yong

Event Start: Mar 13, 2019 1:00 pm
Location: School of Medicine, 132A


Dr. Wee Yong

Professor, University of Calgary
Canada Research Chair in Neuroimmunology
Director, Alberta MS Network
President (2014-2016), International Society of Neuroimmunology



Translational medicine to improve CNS outcomes: successes and challenges

 

This talk will present our experience in translating bench findings to clinical trials particularly in multiple sclerosis to reduce neuroinflammation or to promote remyelination. The scientific rationale of repurposing generic medications and the discovery of new drugs will be highlighted, as will the challenges in translating generic or new drugs in neuroscience.

Dr. V. Wee Yong is a Professor at the University of Calgary. He co-leads the Multiple Sclerosis (MS) NeuroTeam at the university and he directs the Alberta MS Network. Dr. Yong’s research interests lie in the area of neuroimmunology, neuroprotection and CNS regeneration, and his projects are guided by MS and brain tumors.  Dr. Yong has published 295 peer-reviewed manuscripts and his research has been translated into Phase III clinical trials in MS and spinal cord injury; he has just received national funding for a Phase I/IIa trial of niacin in glioblastoma.  His work has been cited over 19,500 times by other authors (web of science; h-index of 78). Dr. Yong is a past chair of the Medical Advisory Committee of the MS Society of Canada; this and other volunteer activities resulted in him receiving the Queen’s Golden Jubilee Year Medallion.  Dr. Yong has been the President of the International Society of Neuroimmunology (2014-2016) and he continues to co-direct its Global Schools of Neuroimmunology. Dr. Yong is an elected fellow of both the Canadian Academy of Health Sciences and the Royal Society of Canada. He is the 2017 Allyn Taylor International Prize in Medicine winner.

Wednesday, March 13th, 2019
1:00 - 2:00 pm
School of Medicine, Room 132A